School of Medicine
Showing 1-31 of 31 Results
-
Israt Alam
Senior Research Scientist-Basic Life, Rad/Molecular Imaging Program at Stanford
BioResearch Focus and interests: Molecular Imaging, PET, Immuno-Oncology, Graft versus Host Disease, CAR T cells
Dr. Israt Alam is a Senior Scientist in the Radiology Department at Stanford University. She trained in Prof. Sanjiv Sam Gambhir's lab and transitioned to Dr. Michelle James' lab in 2021. Her research focuses on studying lymphocyte activation with the motivation of developing non-invasive imaging tools, to monitor immune dynamics in response to cancer immunotherapy and in immunopathology. Her work has supported the clinical translation of several nuclear imaging agents (small molecules and a biologic) for early detection of cancer and prediction of treatment response. She has also worked on several biomarker detection platforms for early disease detection. She is currently co-chair of the "Imaging in cell and immune therapies" (ICIT) interest group for the World Molecular Imaging Society (WMIS).
Appointments:
-Senior Research Scientist, James Lab, Department of Radiology, Stanford
-Life Sciences Research Associate, Gambhir Lab, Department of Radiology, Stanford
-Post-Doctoral Scholar, Gambhir Lab, Department of Radiology, Stanford
-Visiting Researcher /Churchill Travel Fellow in the Plateforme d'imagerie dynamique lab of Prof. Spencer Shorte, Pasteur Institute, Paris
-Science Education Consultant: United Nations Educational, Science and Cultural Organization (UNESCO), Paris
-Science Education Intern: United Nations Educational, Science and Cultural Organization (UNESCO), Paris -
David Anders
Director, Cyclotron and Radiochemistry Facility, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordDirector of the Cyclotron and Radiochemistry Facility
The CRF team is excited to be designing our second cyclotron facility where we will expand production into radiometals. -
Vikram S Bajaj
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioAdj. Professor, Stanford Radiology.
Managing Director, Foresite Capital Management
Co-Founder/CEO, Foresite Labs
Previous:
Chief Scientific Officer, GRAIL
Chief Scientific Officer and Co-Founder, Verily (Google Life Sciences) -
Edwin Chang
Director, Small Animal Imaging Facility at Porter Drive, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordDirector, SCI3@Porter or the Canary Core Preclinical Imaging Facility at Stanford
-
Frezghi Habte
Director, Stanford Center for Innovations in In vivo Imaging (SCi3), Stanford Center for Innovation and In Vivo Imaging
Current Role at StanfordDirector, Stanford Center for Innovation, in In vivo Imaging
-
Ka Chun Ho
Lab Assistant I, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordLab Assistant I - Stanford University, Cyclotron & Radiochemistry Facility
-
Mausam Kalita
Physical Science Research Professional 2, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordSenior Research Scientist: a) cold chemical synthesis— Synthesis of the 12C and 19F- HPLC standards and precursors for 11C- and 18F- labeling
b) Radiosynthesis— Introduction of 11C or 18F radioisotopes into small molecules to develop novel PET tracers, that can track activated myeloid cells in neurodegenerative disease, c) radiometal labeling— 64Cu and 89Zr labeling of monoclonal antibodies that target immune receptors, d) clinical translation— To follow FDA guidelines for translating preclinically validated tracers into humans in the cyclotron and radiochemistry facility (CRF) of the Stanford University -
Jeffrey Howard Kleck
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioJeff Kleck, Ph.D., is an Adjunct Professor at Stanford University and a prominent figure in the Silicon Valley tech venture community. As an established technology and software entrepreneur, he has successfully guided several ventures from concept to becoming market leaders, even taking them public on the NASDAQ. Jeff's leadership roles have included Founder, CEO, and Chairman, shaping these ventures into influential commercial entities.
Currently serving as a Senior Partner at Elevens, Jeff is instrumental in leveraging the expertise of some of the foremost AI minds globally to accelerate breakthrough ventures across multiple sectors. His commitment to advancing technology extends to his role as a Special Government Expert (SGE) for the United States Government, where he acts as a Senior Advisor, identifying and delivering advanced technology for national security. Jeff's previous role as a Highly Qualified Expert (HQE) involved directing transformative and strategic capabilities, promoting the adoption of innovative commercial technologies to enhance national security.
Jeff's involvement in academia is extensive, having served as a visiting scientist at Lawrence Berkeley National Laboratory and Los Alamos National Laboratory, as well as an Adjunct Professor at the University of California Los Angeles (UCLA). His formal education spans various engineering, medical applied science, and technology disciplines, earning a Ph.D. in Biomedical Physics from UCLA, an MS in Engineering Management from Stanford University, an MS in Nuclear Engineering from Texas A&M University, and a BS in Nuclear Engineering from the same institution.
In addition to his contributions at Stanford and Elevens, Jeff has taken on significant roles for the Vatican. Currently, as the Dean of Academics at Catholic Institute of Technology (CIT), he orchestrates cross-disciplinary initiatives, harmonizing theoretical foundations with real-world applications and fostering a culture of innovation. Simultaneously, Jeff serves as the Chairman of Entrepreneurship and Technology Commercialization at CIT, leading the charge in blending academic excellence with practical innovation and overseeing programs that fuse entrepreneurial principles with cutting-edge technology for holistic education.
Jeff is also actively engaged in various ventures, including his role as Chairman of Open Power & Energy Network (OPEN), where he is dedicated to shepherding OPEN toward achieving a sustainable future by seamlessly integrating cutting-edge technologies and best practices, renewing the global climate through accessible power and energy solutions. Additionally, Jeff supports Playground Global, a premier hard tech venture capital firm, as a Friend of Playground.
With a wealth of experience and a commitment to driving innovation, Jeff Kleck continues to shape the landscape of technology, academia, and entrepreneurship.
Reference
Catholic Institute of Technology - https://catholic.tech
Elevens - https://www.elevens.ai
LinkedIn - https://www.linkedin.com/in/jeff-kleck-a000299/
OPEN - https://openpowerenergy.net
Playground - http://playground.vc -
Jason Thanh Lee
Deputy Director, Molecular Imaging Program, Rad/Molecular Imaging Program at Stanford
BioBiomedical imaging scientist in preclinical molecular and nuclear imaging, particularly employing PET, CT and optical techniques. Applications include therapeutic development, oncology, immunotherapy, neuroscience, and molecular biology. Active in translational diagnostics research and development. Lead a scientific team and skilled in project management with a portfolio of academic and pharmaceutical/biotechnology partners. Broad foundation in molecular biology assays and in vivo disease models.
-
Noeen Malik, PhD
Industry Partnership Lead, Lead Radiochemist, R & D Scientist Engineer, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordIndustry Partnership Lead
CRF, MIPS, Stanford School of Medicine, Stanford | May 2024 — present
Lead Radiochemist (R & D Scientist Engineer 2)
CRF, MIPS, Stanford School of Medicine, Stanford | March 2023 — present
Physical Science Research Scientist
CRF, MIPS, Stanford School of Medicine, Stanford | January 2022 — March 2023
Responsibilities:
• R & D of radiopharmaceuticals for oncology and neuroscience
• Industrial collaborations and partnerships
• Drafting and filing drug applications with regulatory agencies (CMCs, INDs)
• Documentation control for audits and in compliance with FDA, Boards of Pharmacy, USP, NRC, and PET CGMP standards.
• Market strategic report for theragnostic-isotopes for Nextgen Cyclotron project
• CRF website development
https://cyclotron.stanford.edu/ -
Arutselvan Natarajan
Senior Research Scientist - Basic Life, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordSenior Scientist
-
Jun Hyung Park
Research and Development Science and Engineer 1, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordI joined in Cyclotron and radiochemstry facility in 2014. I focus on routine radiopharmaceutical production, including 18F tracers (18F-Flumazenil, 18F-FTC-146, 18F-FLT, 18F Arag, 18F-FSPG etc.); 11C tracers (11C UCB-J, 11C-raclopride, 11C-PIB, 11C-methionine, 11C DPA-713 etc.); 15O-H2O and 68Ga-DOTATATE radiochemistry for clinical use and supporting various of pre-clinical studies.
-
Shirin Pourashraf
Physical Science Research Scientist, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordPhysical Science Research Scientist, Academic Staff at Rad/Molecular Imaging Program at Stanford
